T2 Biosystems, Inc. | Business Contracts

Amendment of Solicitation/Modification of Contract, dated as of April 22, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on May 12, 2022)

(Filed With SEC on March 23, 2022)

Non-Employee Director Compensation Program, effective as of March 21, 2022 (Filed With SEC on March 23, 2022)

AMENDMENT No. 7 TO TERM LOAN AGREEMENT (Filed With SEC on March 23, 2022)

Lease, dated September 3, 2021, by and between T2 Biosystems, Inc. and Farley White Concord Road, LLC (Filed With SEC on November 4, 2021)

Amendment of Solicitation/Modification of Contract, dated as of March 31, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on May 12, 2022)

T2 BIOSYSTEMS, INC. INDUCEMENT AWARD PLAN (as amended and restated effective December 17, 2021) ARTICLE 1. PURPOSE (Filed With SEC on March 23, 2022)

OFFER OF EMPLOYMENT (Filed With SEC on March 23, 2022)

Description of Securities (Filed With SEC on March 23, 2022)

(Filed With SEC on March 23, 2022)

Amendment of Solicitation/Modification of Contract, dated as of October 25, 2021 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on November 4, 2021)

Amendment of Solicitation/Modification of Contract, dated as of September 30, 2021 by and between the Company and Biomedical Advanced Research and Development Authority of the... (Filed With SEC on November 4, 2021)

T2 Biosystems, Inc. 2014 Incentive Award Plan, as amended and restated (Filed With SEC on June 28, 2021)

Non-Employee Director Compensation Program, effective as of April 27, 2021 (Filed With SEC on May 13, 2021)

Amendment of Solicitation/Modification of Contract, dated as of April 30, 2021 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on May 13, 2021)

Change of Control Severance Agreement, dated December 31 ,2020, by and between the Company and Dr. Aparna Ahuja (Filed With SEC on March 31, 2021)

Employment Offer Letter, dated as of December 31, 2020, by and between the Company and Dr. Aparna Ahuja (Filed With SEC on March 31, 2021)

Amendment No. 6 to Term Loan Agreement, dated January 25, 2021, between T2 Biosystems, Inc. and CRG Servicing LLC (Filed With SEC on March 31, 2021)

Non-Employee Director Compensation Program, effective as of February 24, 2021 (Filed With SEC on March 31, 2021)

Description of Securities (Filed With SEC on March 31, 2021)

First Amendment to Lease by and between the Company and LS King Hartwell Innovation Campus LLC, dated as of October 19, 2020 (Filed With SEC on November 5, 2020)

Amendment No. 5 to Commercial Lease between Columbus Day Realty, Inc. and the Company, dated as of October 20, 2020 (Filed With SEC on November 5, 2020)

Sixth Amendment to Lease by and between the Company and LS King Hartwell Innovation Campus LLC, dated as of October 19, 2020 (Filed With SEC on November 5, 2020)

Amendment of Solicitation/Modification of Contract, dated as of September 30, 2020 by and between the Company and Biomedical Advanced Research and Development Authority of the... (Filed With SEC on November 5, 2020)

2014 Employee Stock Purchase Plan, as amended and restated effective August 6, 2020 (Filed With SEC on August 12, 2020)

Non-Employee Director Compensation Program, effective as of June 14, 2020 (Filed With SEC on August 12, 2020)

Amendment of Solicitation/Modification of Contract, dated as of July 6, 2020 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on August 12, 2020)

Amendment No. 2 to Equity Distribution Agreement dated as of April 8, 2020 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC (Filed With SEC on April 8, 2020)

Promotion Letter, dated as of January 3, 2020, by and between the Company and Anthony Pare (Filed With SEC on March 16, 2020)

Offer Letter, dated as of March 11, 2019, by and between the Company and Anthony Pare (Filed With SEC on March 16, 2020)

Change in Control Severance Agreement, dated as of March 11, 2019, by and between the Company and Anthony Pare (Filed With SEC on March 16, 2020)

Amendment No. 1 to Equity Distribution Agreement dated as of March 9, 2020 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC (Filed With SEC on March 10, 2020)

T2 Biosystems, Inc. Inducement Award Plan, as amended, and forms of award agreements thereunder (Filed With SEC on January 9, 2020)

Employment Agreement, dated as of January 8, 2020, by and between the Company and John Sperzel (Filed With SEC on January 9, 2020)

Amendment No. 5 to Term Loan Agreement, dated as of September 10, 2019, by and among the Company, CRG Servicing LLC and the lenders listed on the signature pages thereto 31.1*... (Filed With SEC on November 18, 2019)

Second Amendment to Employment Agreement, dated July 30, 2019, between the Company and John McDonough (Filed With SEC on July 30, 2019)

Purchase Agreement dated as of July 29, 2019 by and between T2 Biosystems, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on July 30, 2019)

Equity Distribution Agreement dated as of July 30, 2019 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC (Filed With SEC on July 30, 2019)

Registration Rights Agreement dated as of July 29, 2019 by and between T2 Biosystems, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on July 30, 2019)

Non-Employee Director Compensation Program, effective as of February 21, 2019 (Filed With SEC on May 10, 2019)

GE Catalog Supply Agreement OEM Retail, dated March 15, 2019, by and between the Company and GE Healthcare Bio-Sciences Corp (Filed With SEC on May 10, 2019)

Change of Control Severance Agreement, dated October 29, 2014, by and between the Company and Michael Gibbs (Filed With SEC on March 14, 2019)

Employment Offer Letter, dated as of October 29, 2014, by and between the Company and Michael Gibbs (Filed With SEC on March 14, 2019)

T2 Biosystems, Inc. Inducement Award Plan (as amended and restated, effective February 21, 2019) and form of option agreement, restricted stock agreement, and restricted stock... (Filed With SEC on March 14, 2019)

Amendment to Change of Control Severance Agreement, by and between the Company and Michael Gibbs, dated June 6, 2017 (Filed With SEC on March 14, 2019)

Separation Agreement, dated January 30, 2018, by and between the Company and Darlene Deptula-Hicks (Filed With SEC on March 14, 2019)

Separation Agreement, dated March 13, 2018, by and between the Company and Joanne Spadoro (Filed With SEC on March 14, 2019)

Non-Employee Director Compensation Program, effective as of February 21, 2019 (Filed With SEC on March 14, 2019)

T2 Biosystems, Inc. (51)